Evidence of Partial Anti-Enuretic Response Related to Poor Pharmacodynamic Effects of Desmopressin Nasal Spray

Journal of Urology

Volumn 181, Issue 1, 2009, Pages 302-309

  De Guchtenaere, Ann ^a   Raes, Ann ^a   Vande Walle, Caroline ^a   Hoebeke, Piet ^a   Van Laecke, Erik ^a   Donckerwolcke, Raymond ^a   Vande Walle, Johan ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

deamino arginine vasopressin; drug resistance; nocturnal enuresis; pharmacokinetics; treatment failure

Indexed keywords

DESMOPRESSIN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG URINE LEVEL; FEMALE; FLUID INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURNAL ENURESIS; PRIORITY JOURNAL; URINE OSMOLALITY;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ANTIDIURETIC AGENTS; CHILD; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; NOCTURNAL ENURESIS; TREATMENT FAILURE;

EID: 57149095622     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.09.040     Document Type: Article

References (22)

1. Neveus T., Lackgren G., Tuvemo T., Hetta J., Hjalmas K., and Stenberg A. Enuresis-background and treatment. Scand J Urol Nephrol, suppl 206 (2000) 1
2. Neveus T., von Gontard A., Hoebeke P., Hjalmas K., Bauer S., Bower W., et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol 176 (2006) 314
3. Rittig S., Knudsen U.B., Norgaard J.P., Pedersen E.B., and Djurhuus J.C. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 256 (1989) F664
4. Hunsballe J.M., Hansen T.K., Rittig S., Pedersen E.B., and Djurhuus J.C. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis. Clin Endocrinol (Oxf) 49 (1998) 793
5. Hjalmas K., Hanson E., Hellstrom A.L., Kruse S., and Sillen U. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. Br J Urol 82 (1998) 704
6. Norgaard J.P., van Gool J.D., Hjalmas K., Djurhuus J.C., and Hellstrom A.L. Standardization and definitions in lower urinary tract dysfunction in children. International Children's Continence Society. Br J Urol, suppl. 81 (1998) 1
7. Glazener C.M., and Evans J.H. Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev 2 (2000) CD002112
8. Kamperis K., Rittig S., Jorgensen K.A., and Djurhuus J.C. Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. Am J Physiol Renal Physiol 291 (2006) F1232
9. Raes A., Dehoorne J., Hoebeke P., Van Laecke E., Donckerwolcke R., and Vande Walle J. Abnormal circadian rhythm of diuresis or nocturnal polyuria in a subgroup of children with enuresis and hypercalciuria is related to increased sodium retention during daytime. J Urol 176 (2006) 1147
10. Kamperis K., Hansen M.N., Hagstroem S., Hvistendahl G., Djurhuus J.C., and Rittig S. The circadian rhythm of urine production, and urinary vasopressin and prostaglandin E2 excretion in healthy children. J Urol 171 (2004) 2571
11. Kuznetsova A.A., Shakhmatova E.I., Prutskova N.P., and Natochin Y.V. Possible role of prostaglandins in pathogenesis of nocturnal enuresis in children. Scand J Urol Nephrol 34 (2000) 27
12. Dehoorne J.L., Raes A.M., van Laecke E., Hoebeke P., and Vande Walle J.G. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion. J Urol 176 (2006) 749
13. Hansen M.N., Rittig S., Siggaard C., Kamperis K., Hvistendahl G., Schaumburg H.L., et al. Intra-individual variability in nighttime urine production and functional bladder capacity estimated by home recordings in patients with nocturnal enuresis. J Urol 166 (2001) 2452
14. Dehoorne J.L., Walle C.V., Vansintjan P., Raes A.M., De Guchtenaere A.R., Van Laecke E., et al. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response. J Urol 177 (2007) 1130
15. Vande Walle J.G., Bogaert G.A., Mattsson S., Schurmans T., Hoebeke P., Deboe V., et al. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int 97 (2006) 603
16. Osterberg O., Savic R.M., Karlsson M.O., Simonsson U.S., Norgaard J.P., Walle J.V., et al. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. J Clin Pharmacol 46 (2006) 1204
17. Hjalmas K., Arnold T., Bower W., Caione P., Chiozza L.M., von Gontard A., et al. Nocturnal enuresis: an international evidence based management strategy. J Urol 171 (2004) 2545
18. Monnens L., Smulders Y., van Lier H., and de Boo T. DDAVP test for assessment of renal concentrating capacity in infants and children. Nephron 29 (1981) 151
19. Valenti G., Laera A., Pace G., Aceto G., Lospalluti M.L., Penza R., et al. Urinary aquaporin 2 and calciuria correlate with the severity of enuresis in children. J Am Soc Nephrol 11 (2000) 1873
20. Valenti G., Laera A., Gouraud S., Pace G., Aceto G., Penza R., et al. Low-calcium diet in hypercalciuric enuretic children restores AQP2 excretion and improves clinical symptoms. Am J Physiol Renal Physiol 283 (2002) F895
21. Robson W.L., Leung A.K., and Norgaard J.P. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol 178 (2007) 24
22. Dehoorne J.L., Raes A.M., van Laecke E., Hoebeke P., and Vande Walle J.G. Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J Urol 176 (2006) 754